Wall Street analysts predict lower second-quarter profits for Ford, GM and Stellantis due to tariff pressures and slowing sales.

The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

Denim powerhouse has resurrected fading brand by paying down debt, cutting costs and revamping its supply chain ...

Trump told reporters last week that he had talks with Congress members of removing the Central Bank Chair, during which he ...

President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in ...